Trademark Attorney / Law Firm
Matthew M. Gorman – Trademark Portfolio
Matthew M. Gorman specializes in Class 3 (Cosmetics & Cleaning) trademark filings before the United States Patent and Trademark Office (USPTO), with 18 of 23 total filings concentrated in this category. The practice also covers Class 44 (Medical Services) along with 3 other Nice Classification classes. Filing activity spans from 2021 to 2022. Currently, 1 trademark is registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Matthew M. Gorman's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has Matthew M. Gorman filed?
Matthew M. Gorman has filed 23 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 22 abandoned.
What trademark classes does Matthew M. Gorman specialize in?
Matthew M. Gorman has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
How long has Matthew M. Gorman been filing trademarks?
Matthew M. Gorman's trademark filing history with the USPTO spans from 2021 to 2022, covering 1 year of trademark practice. During this period, Matthew M. Gorman has handled 23 trademark applications.
What is Matthew M. Gorman's trademark registration success rate?
Matthew M. Gorman has a 4% trademark registration rate, with 1 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.